Related Experiment Video
Updated: Jun 27, 2026
07:13
Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity
Published on: January 6, 2015
11.1K
Diffuse alveolar damage: a common phenomenon in progressive interstitial lung disorders
Riitta Kaarteenaho1, Vuokko L Kinnula
1Respiratory Research Unit, Department of Internal Medicine, Centre of Excellence in Research, and Clinical Research Center, Institute of Clinical Medicine, Oulu University Hospital, University of Oulu, P.O. Box 22, 90029 Oulu, Finland.
Pulmonary Medicine
|June 4, 2011
Summary
Rapidly progressing lung diseases, including interstitial lung diseases and viral infections, share diffuse alveolar damage (DAD) as a common endpoint. Understanding DAD mechanisms is crucial for treating these severe conditions.
Area of Science:
- Pulmonary Medicine
- Pathology
- Infectious Diseases
Background:
- Interstitial lung diseases (ILDs) and viral lung infections can present with similar rapid progression and lung morphology.
- Diffuse alveolar damage (DAD) is a common histopathological endpoint in various acute lung disorders.
- DAD signifies an end-stage phenomenon in acute interstitial pneumonias (AIP) and idiopathic pulmonary fibrosis (IPF) exacerbations.
Purpose of the Study:
- To highlight the shared histopathological feature of diffuse alveolar damage (DAD) in rapidly progressing lung diseases.
- To emphasize the need for understanding the mechanisms underlying DAD.
- To call for international collaborative efforts in studying DAD-associated lung diseases.
Main Methods:
- Histopathological analysis of lung tissue.
- Review of clinical presentations of interstitial lung diseases and viral infections.
- Comparative analysis of disease progression and outcomes.
Main Results:
- Diffuse alveolar damage (DAD) is a consistent finding in acute interstitial pneumonia (AIP), acute exacerbations of idiopathic pulmonary fibrosis (IPF), and severe viral lung infections.
- Rapid progression and similar lung morphology are observed across these distinct conditions.
- The prognosis for patients with DAD-associated lung diseases remains poor.
Conclusions:
- A deeper understanding of DAD pathogenesis is essential for developing effective treatments.
- International collaboration is urgently needed to advance research in DAD-associated lung diseases.
- Improved therapeutic strategies are required given the dismal prognosis of these conditions.
Related Concept Videos
01:29Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps:
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:10Atelectasis II: Pathophysiology
Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...